A detailed history of Awm Investment Company, Inc. transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Awm Investment Company, Inc. holds 2,285,000 shares of RNXT stock, worth $2.7 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
2,285,000
Holding current value
$2.7 Million
% of portfolio
0.36%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$0.91 - $1.51 $2.08 Million - $3.45 Million
2,285,000 New
2,285,000 $2.26 Million

Others Institutions Holding RNXT

About RenovoRx, Inc.


  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $10.7M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track This Portfolio

Track Awm Investment Company, Inc. Portfolio

Follow Awm Investment Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Awm Investment Company, Inc. with notifications on news.